Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Center for the Prevention and Treatment of Visual Loss

Menu
Menu
Quick Links
Veterans Crisis Line Badge
My healthevet badge
 

Dr. Greiner

   

Mark A. Greiner, MD

Investigator, Center for the Prevention and Treatment of Visual Loss

Phone: (319) 356-2861

Email: mark-greiner@uiowa.edu

Education

BA, English, University of California, Berkeley

MD, Medicine, University of California, Davis School of Medicine

Internship, University of California, Davis Medical Center, Internal Medicine

Residency, Ophthalmology Resident, University of California, David Health System Eye Center

Fellowship, Cornea, Clinical Fellowship, Devers Eye Institute, Portland, Oregon

Highlighted Publications

  1. Naguib YW, Saha S, Skeie JM, Acri T, Ebeid K, Abdel-Rahman S, Kesh S, Schmidt GA, Nishimura DY, Banas JA, Zhu M, Greiner MA, Salem AK. Solubilized ubiquinol for preserving corneal function. Biomaterials. 2021 Aug;275:120842. doi: 10.1016/j.biomaterials.2021.120842. Epub 2021 May 1. PubMed PMID: 34087583; PubMed Central PMCID: PMC8325625.
  1. Kingsbury KD, Skeie JM, Cosert K, Schmidt GA, Aldrich BT, Sales CS, Weller J, Kruse F, Thomasy SM, Schlötzer-Schrehardt U, Greiner MA. Type II Diabetes Mellitus Causes Extracellular Matrix Alterations in the Posterior Cornea That Increase Graft Thickness and Rigidity. Invest Ophthalmol Vis Sci. 2023 Jun 1;64(7):26. doi: 10.1167/iovs.64.7.26. PubMed PMID: 37326594; PubMed Central PMCID: PMC10281062.
  1. Fortenbach CR, Skeie JM, Sevcik KM, Johnson AT, Oetting TA, Haugsdal JM, Sales CS, Nishimura DY, Taylor EB, Schmidt GA, Greiner MA. Metabolic and proteomic indications of diabetes progression in human aqueous humor. PLoS One. 2023;18(1):e0280491. doi: 10.1371/journal.pone.0280491. eCollection 2023. PubMed PMID: 36652491; PubMed Central PMCID: PMC9847982.
  1. Leonard BC, Park S, Kim S, Young LJ, Jalilian I, Cosert K, Zhang X, Skeie JM, Shevalye H, Echeverria N, Rozo V, Gong X, Xing C, Murphy CJ, Greiner MA, Mootha VV, Raghunathan VK, Thomasy SM. Mice Deficient in TAZ (Wwtr1) Demonstrate Clinical Features of Late-Onset Fuchs' Endothelial Corneal Dystrophy. Invest Ophthalmol Vis Sci. 2023 Apr 3;64(4):22. doi: 10.1167/iovs.64.4.22. PubMed PMID: 37074694; PubMed Central PMCID: PMC10132321.
return to top go